Cargando…

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer

INTRODUCTION: Approximately 30% of patients diagnosed with stage Ia-b NSCLC die of recurrent disease after surgery. This study aimed to identify immune-related biomarkers that might predict tumor recurrence in stage Ia-b NSCLC within 40 months after curative resection. METHODS: Gene expression data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qiang, Zhou, Danting, Wu, Fang, Liang, Qingchun, He, Qiongzhi, Peng, Muyun, Yao, Tianyu, Hu, Yan, Qian, Banglun, Tang, Jingqun, Wang, Xiang, Liu, Wenliang, Yu, Fenglei, Chen, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356052/ https://www.ncbi.nlm.nih.gov/pubmed/34395248 http://dx.doi.org/10.3389/fonc.2021.680287

Ejemplares similares

Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer
por: Yu, Fenglei, et al.
Publicado: (2023)

Real‐world comprehensive diagnosis and “Surgery + X” treatment strategy of early‐stage synchronous multiple primary lung cancer
por: Zhou, Danting, et al.
Publicado: (2023)

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
por: Peng, Muyun, et al.
Publicado: (2020)

A novel technique for preoperative localization of pulmonary nodules using a mixture of tissue adhesive and iohexol under computed tomography guidance: A 140 patient single‐center study
por: Zhang, Bingyu, et al.
Publicado: (2021)

The role of lipid metabolism in tumor immune microenvironment and potential therapeutic strategies
por: Wang, Danting, et al.
Publicado: (2022)

Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis
por: Yang, Wei-Yu, et al.
Publicado: (2022)

Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution
por: Liu, Jun, et al.
Publicado: (2023)

Deep learning-enhanced radiomics for histologic classification and grade stratification of stage IA lung adenocarcinoma: a multicenter study
por: Pei, Guotian, et al.
Publicado: (2023)

Stage IA Patients With Pancreatic Ductal Adenocarcinoma Cannot Benefit From Chemotherapy: A Propensity Score Matching Study
por: Zhang, Yuchao, et al.
Publicado: (2020)

The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer
por: Liu, Zhao, et al.
Publicado: (2021)

CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer
por: Fan, Shuxuan, et al.
Publicado: (2021)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Adjuvant Radiotherapy After Minimally Invasive Surgery in Patients With Stage IA1-IIA1 Cervical Cancer
por: Gan, Yi-xiu, et al.
Publicado: (2021)

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas
por: Zhan, Xiangbo, et al.
Publicado: (2019)

Prognostic Impact of Radiological Consolidation Tumor Ratio in Clinical Stage IA Pulmonary Ground Glass Opacities
por: Xi, Junjie, et al.
Publicado: (2021)

Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer
por: Ronsini, Carlo, et al.
Publicado: (2022)

A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection
por: Hu, Chunhong, et al.
Publicado: (2022)

Transient Palsy of Recurrent Laryngeal Nerve Postresection of Giant Substernal Goiter
por: Muhoozi, Rwakaryebe, et al.
Publicado: (2014)

Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma
por: Yu, Mei, et al.
Publicado: (2020)

Crosstalk of MicroRNAs and Oxidative Stress in the Pathogenesis of Cancer
por: Lu, Can, et al.
Publicado: (2020)

The Value of CT-Based Radiomics for Predicting Spread Through Air Spaces in Stage IA Lung Adenocarcinoma
por: Han, Xiaoyu, et al.
Publicado: (2022)

Report on 153 sequential three-incision robotic-assisted pulmonary resections by a single surgeon: technical details and learning curve
por: Peng, Muyun, et al.
Publicado: (2020)

Review of biomarkers for response to immunotherapy in HNSCC microenvironment
por: Chen, Shaoshi, et al.
Publicado: (2023)

Exploring pathological signatures for predicting the recurrence of early-stage hepatocellular carcinoma based on deep learning
por: Qu, Wei-Feng, et al.
Publicado: (2022)

Segmentectomy for stage IA3 tumours: just another day in clinic
por: Brunelli, Alessandro
Publicado: (2023)

Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma
por: Jiang, Aimin, et al.
Publicado: (2021)

The Ferroptosis-Related Noncoding RNA Signature as a Novel Prognostic Biomarker in the Tumor Microenvironment, Immunotherapy, and Drug Screening of Gastric Adenocarcinoma
por: Chen, Xinming, et al.
Publicado: (2021)

Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching’s Study
por: Zhang, Bo, et al.
Publicado: (2021)

Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis
por: Shao, Shengteng, et al.
Publicado: (2022)

Genomic profile and immune microenvironment in patients with relapsed stage IA lung adenocarcinoma
por: Yang, Lu, et al.
Publicado: (2020)

Prognosis of segmentectomy in the treatment of stage IA non-small cell lung cancer
por: Bai, Wenliang, et al.
Publicado: (2021)

Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses
por: Chen, Donglai, et al.
Publicado: (2021)

A Machine-Learning Approach to Developing a Predictive Signature Based on Transcriptome Profiling of Ground-Glass Opacities for Accurate Classification and Exploring the Immune Microenvironment of Early-Stage LUAD
por: Zhao, Zhenyu, et al.
Publicado: (2022)

Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules
por: Chen, Chen, et al.
Publicado: (2020)

The role of TGR5 as an onco-immunological biomarker in tumor staging and prognosis by encompassing the tumor microenvironment
por: Guan, Zhiyuan, et al.
Publicado: (2022)

HAMP as a Prognostic Biomarker for Colorectal Cancer Based on Tumor Microenvironment Analysis
por: Wei, Fang-Ze, et al.
Publicado: (2022)

A Comparison of Laparoscopies and Laparotomies for Radical Hysterectomy in Stage IA1-IB1 Cervical Cancer Patients: A Single Team With 18 Years of Experience
por: Qin, Meng, et al.
Publicado: (2020)

Microbiome Related Cytotoxically Active CD8+ TIL Are Inversely Associated With Lung Cancer Development
por: Zheng, Leliang, et al.
Publicado: (2020)

Clinical Significance and Immune Landscape of Recurrence-Associated Ferroptosis Signature in Early-Stage Lung Adenocarcinoma
por: Yi, Lilan, et al.
Publicado: (2022)

Possible Oncogenic Viruses Associated with Lung Cancer
por: Hu, Yan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5r4jakukrrkuk916cdu74g4kh3